Genetics Flashcards
AML translocations
t(8;21) RUNX1-RUNX1T1 inv(16) or t(16;16) CBFB-MYH11 t(15;17) PML-RARA t(9;11) MLLT3-KMT2A t(6:9) DEK-NUP214 inv(3) or t(3;3) GATA2 t(1;22) RBM15-MKL1 t(9;22) NPM1 CEBPA
T21 AML mutation
GATA1
MDS mutations
Monosomy 7
Monosomy 5
-5q deletion
-7q deletion
AML favorable mutations
CEBP alpha NPM1 GATA1 t(8;21) inv(16) or t(16;16) t(15;17) t(1;11)
AML unfavorable genetics
FLT3-ITD
c-KIT
MDS
t(6;11), t(10;11)
ALL translocations
t(12;21) ETV6-RUNX1 t(1;19) TCF3-PBX1 t(17;19) TCF3-HLF (DIC) 11q23 MLL - t(4;11) most common t(9;22) BCR-ABL t(5;14) IL3-IGH (hypereosinophilia) hylerdiploidy/hypodiploidy Trisomy 4, 10, 17
CRLF2 gene overexpression (Ph like)
t(8;14), t(2;8), t(8;22) - Burkitt Leukemia
ALL favorable genetics
Hyperdiploid (>50)
Trisomy 4, 10, 17
t(12;21) ETv6-RUNX1
ALL unfavorable genetics
hypodiploid (< 44) MLL (KMT2A) t(9;22) iAMP21 t(17;19)
T21 ALL
absence of favorable genetics
1/3 have JAK2 and unique fusion between P2RY8 and CRLF2 leading to CRLF2 overexpression
Burkitt lymphoma translocations
t(8;14)
t(2;8)
t(8;22)
C-MYC
IGH
IGK
IGL
Primary mediastinal B cell genetics
9p and 2p gains
JAK2
C-rel
SOCS1
Lymphoblastic lymphoma genetics
Deletion TAL1
t(1;14)
t(11;14)
LOH at 6q
TAL1 TCRAO RHOMB1 HOX11 NOTCH1
ALCL translocations
t(2;5)
ALK
NPM
Diffuse Large B Cell lymphoma genetics
2/3 express BCL-6
1/3 express cMYC
Activated B cell like t(14;18)
IRF4 translocations (favorable)
Hodgkin lymphoma genetics
NFkB
9p24.1 alterations lead to increased PDL1
Familial neuroblastoma genetics
ALK
PHOX2B (Hirschprung’s, central hypoventilation)
Deletion 1p36 or 11q14-23
Sporadic NBL gremline mutations
NF-1
WT2
TP53
PTPN11
Neuroblastoma genetics changes (non-hereditary)
Myc-N amplification 17q gain 1p36 (MYCNA) 11q23 14q32 Whole chromosome gains ALK ATRX ARID1a/1b Ras pathway
Syndromic Wilms genetics
11p13 WT1 - WAGR 11p13 WT1 - Denys-Drash 11p13 WT1 - Frasier 11p15 WT2 - BWS/isolated hemihypertrophy 2q37 DIS3L2 - Perlman 15q15 BUB1B - mosaic variegated aneuploidy 13q12 BRCA2 - fanconi anemia Xp26 GPC3 - Simpson-Golabi-Behmel P53
Wilms genetic alterations
WT1 deletion/mutation 11p15 paternal uniparental disomy WTX CTNNB1 - WT1 associated (exon 3 deletion) or WTX associated (exon 7 and 8 deletions) P53 LOH 1p and 16q 1q gain DICER1 loss of function DROSHA loss of function SIX1/2 mutations PTCH MYC-N
Congenital mesoblastic nephroma translocations
t(12;15) - cellular CMN
Rhabdoid tumor
SMARCB1 (lack of INI1)
SMARCA4
Rental cell carcinoma genetics
TFE3 gene on X chromosome
VHL- 3p26 deletion (tumor suppression)
Familial RCC - chromosome 3 translocation, succinate dehydrogenase (SDHB, SDHC, SDHD) mutation with pheochromocytoma
Embryonal RMS genetics
LOH at 11p15
Alveolar RMS genetics
FOXO1-PAX3 t(2;13)
FOXO1-PAX7 t(1;13)
Synovial sarcoma translocation
t(X;18) SSX1-SYT
Dermatofibrosarcoma protuberans translocation
t(17;22) COL1A1-PDGFB
Malignant fibrous histiocytoma
19p+
Angiomatoid fibrous histiocytoma
t(2;22)
t(12;16)
t(12;22)
EWSR1-CREB1
TLS-ATF1
EWSR1-ATF1
MPNST translocation
17q, 22q loss or rearrangement
Fibrosarcoma translocations
t(X;18)
t(2;5)
t(7;22)
Infantile fibrosarcoma translocations
t(12;15) ETV6-NTRK3
Leiomyosarcoma translocations
Deletion 1p
t(12;14)
HMGA2 rearrangement
Alveolar soft part sarcoma translocation
t(X;17) ASPSCR1-TFE3
Hemangiopericytoma infantile form translocation
t(12;19)
t(13;22)
Liposarcoma (myxoid) translocation
t(12;16) FUS-DDIT3
Clear cell sarcoma translocation
t(12;22) EWSR1-ATF1
Desmoplastic small round blue cell tumor translocation
t(11;22) EWS/WT1
Ewing sarcoma translocations
t(11;22) - most common, EWS-FLI1
t(21;22) EWS-ERG
Chromosomal changes in 1 and 16
Trisomy 8 and 12
Osteosarcoma common genetic alterations
P53 (17p13)
RB1 (13q14)
Bloom syndrome RecQL3 (15q26.1)
Rothmund-Thomson RecQL4 (8q24.3)
Retinoblastoma genetics
RB1 (13q14) tumor suppressor
P53 (MDM2, MDM4 amplification)
BCOR mutations
SYK upregulation
Testicular GCT cytogenetics
Prepubertal: 6p and 1q deletions
Adolescents: i(12p), loss of 13, +21
Extragonadal: +X
Brain tumor predisposition syndromes and their mutation
NF1: 17q11.2 Neurofibromin NF2: 22q12.2 Merlin TS: 9q34, 16p13.3 hamartin and Tuberin Li-Fraumeni: 17p13.1 TP53 VHL: 3p25.3 VHL Turcot: 5q21-22, 3p21 APC Gordon: 9q22 PTCH1
LGG genetics
BRAF-K1AA1549 fusion
BRAF V600E mutations
FGFR1, PTPN11, NTRK2 fusion
DIPG genetics
H3K27M
ATRT mutation
SMARCB1 (INI1 negative)
SMARCA4
Cancers associated with BWS
Wilms Hepatoblastoma Neuroblastoma rhabdomyosarcoma Adrenocorical carcinoma